Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2019
Headcount
1-10
HQ
Rishon LeTsiyon, Israel
Sector
Health Tech & Life Sciences
About
SCINNABIS develops medical cannabis solutions. The company separates and re-integrates the active ingredients in cannabis to develop personalized medicine for specific medical indications. In so doing, SCINNABIS creates accurate, science-based products containing specific compositions to treat different medical indications.
Q&A
- What is SCINNABIS's primary business focus?
- SCINNABIS develops science-based medical cannabis products by separating and re-integrating active ingredients to create personalized medicine for specific medical indications.
- When was SCINNABIS founded?
- SCINNABIS was founded in July 2019.
- What is the current status of SCINNABIS?
- SCINNABIS is currently inactive and ceased to operate in October 2021.
- Where is SCINNABIS headquartered?
- SCINNABIS is headquartered in Rishon LeTsiyon, Israel.
- Who are the co-founders of SCINNABIS?
- The co-founders of SCINNABIS are Ben Peretz (Co-founder & CEO) and Moran Mazuz (Co-founder & CTO).
- What is SCINNABIS's primary sector classification?
- SCINNABIS's primary sector classification is Health Tech & Life Sciences.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
treatmentspharma-companieschronic-patientspersonalized-medicineparentspharmaceuticalsnatural-active-ingredientscannabismedical-cannabis
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/15785795 |
Identifiers & details
| Founded | 2019-7 |
|---|---|
| Status reason | Non Active, Oct 2021 ceased to operate |